Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.
Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J.
Murchie AI, et al. Among authors: karn j.
J Mol Biol. 2004 Feb 20;336(3):625-38. doi: 10.1016/j.jmb.2003.12.028.
J Mol Biol. 2004.
PMID: 15095977